View in EDS

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

Saved in:
Bibliographic Details
Title: Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
Authors: Morel KL; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia., Germán B; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Nanda JS; Division of Hematology and Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Linder S; Division of Oncogenomics, Oncode Institute., Bergman AM; Division of Oncogenomics, Oncode Institute.; Division of Medical Oncology., van der Poel H; Division of Urology., Hofland I; Core Facility Molecular Pathology and Biobanking; and., Bekers EM; Division of Pathology; Netherlands Cancer Institute, Amsterdam, Netherlands., Trostel SY; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Burkhart DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Wilkinson S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Ku AT; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Kim M; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Kim J; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Ma D; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Plummer JT; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., You S; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA., Su XA; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Zwart W; Division of Oncogenomics, Oncode Institute., Sowalsky AG; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Ellis L; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Nov 19; Vol. 135 (2). Date of Electronic Publication: 2024 Nov 19.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39560993
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Morel+KL%22">Morel KL</searchLink>; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Germán+B%22">Germán B</searchLink>; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Hamid+AA%22">Hamid AA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Nanda+JS%22">Nanda JS</searchLink>; Division of Hematology and Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Linder+S%22">Linder S</searchLink>; Division of Oncogenomics, Oncode Institute.<br /><searchLink fieldCode="AU" term="%22Bergman+AM%22">Bergman AM</searchLink>; Division of Oncogenomics, Oncode Institute.; Division of Medical Oncology.<br /><searchLink fieldCode="AU" term="%22van+der+Poel+H%22">van der Poel H</searchLink>; Division of Urology.<br /><searchLink fieldCode="AU" term="%22Hofland+I%22">Hofland I</searchLink>; Core Facility Molecular Pathology and Biobanking; and.<br /><searchLink fieldCode="AU" term="%22Bekers+EM%22">Bekers EM</searchLink>; Division of Pathology; Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Trostel+SY%22">Trostel SY</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Burkhart+DL%22">Burkhart DL</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wilkinson+S%22">Wilkinson S</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ku+AT%22">Ku AT</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kim+M%22">Kim M</searchLink>; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Ma+D%22">Ma D</searchLink>; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Plummer+JT%22">Plummer JT</searchLink>; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22You+S%22">You S</searchLink>; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Su+XA%22">Su XA</searchLink>; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zwart+W%22">Zwart W</searchLink>; Division of Oncogenomics, Oncode Institute.<br /><searchLink fieldCode="AU" term="%22Sowalsky+AG%22">Sowalsky AG</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sweeney+CJ%22">Sweeney CJ</searchLink>; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+L%22">Ellis L</searchLink>; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Nov 19; Vol. 135 (2). <i>Date of Electronic Publication: </i>2024 Nov 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39560993
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI175680
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Morel KL
      – PersonEntity:
          Name:
            NameFull: Germán B
      – PersonEntity:
          Name:
            NameFull: Hamid AA
      – PersonEntity:
          Name:
            NameFull: Nanda JS
      – PersonEntity:
          Name:
            NameFull: Linder S
      – PersonEntity:
          Name:
            NameFull: Bergman AM
      – PersonEntity:
          Name:
            NameFull: van der Poel H
      – PersonEntity:
          Name:
            NameFull: Hofland I
      – PersonEntity:
          Name:
            NameFull: Bekers EM
      – PersonEntity:
          Name:
            NameFull: Trostel SY
      – PersonEntity:
          Name:
            NameFull: Burkhart DL
      – PersonEntity:
          Name:
            NameFull: Wilkinson S
      – PersonEntity:
          Name:
            NameFull: Ku AT
      – PersonEntity:
          Name:
            NameFull: Kim M
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Ma D
      – PersonEntity:
          Name:
            NameFull: Plummer JT
      – PersonEntity:
          Name:
            NameFull: You S
      – PersonEntity:
          Name:
            NameFull: Su XA
      – PersonEntity:
          Name:
            NameFull: Zwart W
      – PersonEntity:
          Name:
            NameFull: Sowalsky AG
      – PersonEntity:
          Name:
            NameFull: Sweeney CJ
      – PersonEntity:
          Name:
            NameFull: Ellis L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 11
              Text: 2024 Nov 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 135
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1